High-dose CU262 in particular brought IL-6/TNF-α down and IL-10 up relative to HFD alone (p < 0.05), indicating an attenuation of obesity-associated systemic inflammation. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.